Concepts of Myelin and Myelination in Neuroradiology

References

1. ↵
   Brant-Zawadzki M, Enzmann DR. Using computed tomography of the brain to correlate low white matter attenuation with early gestational age in neonates. Radiology 1981;139:105-108

   PubMed
2. ↵
   Morell P, Quarles RH, Norton WT. Myelin formation, structure, and biochemistry. In: Siegel GJ, ed. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 5th ed. New York: Raven Press 1994 117-143
3. ↵
   Brady ST, Witt AS, Kirkpatrick LL, et al. Formation of compact myelin is required for maturation of the axonal cytoskeleton. J Neurosci 1999;19:7278-7288

   Abstract/FREE Full Text
4. Kirchner DA, Blaurock AE. Organization, phylogenetic variations and dynamic transitions of myelin. In: Martenson RE, ed. Myelin: Biology and Chemistry. Boca Raton: CRC 1991 413-448
5. ↵
   Kirschner DA, Ganser AL. Myelin labeled with mercuric chloride: asymmetric localization of phosphatidylethanolamine plasmalogen. J Mol Biol 1982;157:635-658

   PubMed
6. ↵
   Braun PE. Molecular organization of myelin. In: Morell P, ed. Myelin. New York: Plenum Press 1984 97-116
7. ↵
   van der Knaap MJ, Valk J. Myelin and white matter. In: van der Knaap MJ, Valk J, eds. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin: Springer 1995 1-17
8. ↵
   Lee J, Barry JA. Influence of membrane lipid packing on T2-weighted magnetic resonance images: study of relaxation parameters in model membrane systems. Magn Reson Med 1996;36:420-426

   PubMed
9. ↵
   Jacobson M. Developmental Neurobiology. 3rd ed. New York: Plenum Press 1991 776
10. ↵
    Weimbs T, Stoffel W. Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide bonded, and fatty acid thioester-linked cysteine residues: implications for the membrane topology of PLP. Biochemistry 1992;31:12289-12296

    CrossRefPubMed
11. ↵
    Knapp PE. Proteolipid protein: is it more than just a structural component of myelin? Dev Neurosci 1996;18:297-308

    PubMedWeb of Science
12. Griffiths I, Klugmann M, Anderson T, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998;280:1610-1613

    Abstract/FREE Full Text
13. ↵
    Coetzee T, Suzuki K, Popko B. New perspectives on the function of myelin galactolipids. Trends Neurosci 1998;21:126-130

    CrossRefPubMedWeb of Science
14. ↵
    Quarles RH. Glycoproteins of myelin sheaths. J Mol Neurosci 1997;8:1-12

    PubMedWeb of Science
15. ↵
    Li C, Tropak MB, Gerlai R, et al. Myelination in the absence of myelin-associated glycoprotein. Nature 1994;369:747-750

    CrossRefPubMedWeb of Science
16. Schnaar RL, Collins BE, Wright LP, et al. Myelin-associated glycoprotein binding to gangliosides: structural specificity and functional implications. Ann N Y Acad Sci 1998;845:92-105

    CrossRefPubMedWeb of Science
17. ↵
    Quarles RH. Myelin-associated glycoprotein in development and disease. Dev Neurosci 1985;6:285-303
18. Trapp BD. Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve. J Cell Biol 1988;107:675-685

    Abstract/FREE Full Text
19. ↵
    Konat GW. Chromatin structure and transcriptional activity of MAG gene. Acta Neurobiol Exp (Warsz) 1996;56:281-285

    PubMed
20. ↵
    Barkovich AJ, Kjos BO, Jackson DE Jr, Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 1988;166:173-180

    PubMedWeb of Science
21. Bird CR, Hedberg M, Drayer BP, Keller PJ, Flom RA, Hodak JA. MR assessment of myelination in infants and children: usefulness of marker sites. AJNR Am J Neuroradiol 1989;10:731-740

    Abstract/FREE Full Text
22. Christophe C, Muller MF, Baleriaux D, et al. Mapping of normal brain maturation in infants on phase-sensitive inversion-recovery images. Neuroradiology 1990;32:173

    CrossRefPubMedWeb of Science
23. Dietrich RB, Bradley WG, Zagaroza EJ, et al. MR evaluation of early myelination patterns in normal and developmentally delayed infants. AJR Am J Roentgenol 1988;150:889-896

    CrossRefPubMedWeb of Science
24. ↵
    Holland BA, Haas DK, Norman D, Brant-Zawadzki M, Newton TH. MRI of normal brain maturation. AJNR Am J Neuroradiol 1986;7:201-208

    Abstract/FREE Full Text
25. McArdle CB, Richardson CJ, Nicholas DA, Mirfakhraee M, Hayden CK, Amparo EG. Developmental features of the neonatal brain: MR imaging: part I: gray-white matter differentiation and myelination. Radiology 1987;162:223-229

    PubMedWeb of Science
26. van der Knaap MS, Valk J. MR imaging of the various stages of normal myelination during the first year of life. Neuroradiology 1990;31:459-470

    CrossRefPubMedWeb of Science
27. Martin E, Kikinis R, Zuerrer M, et al. Developmental stages of the human brain: an MR study. J Comput Assist Tomogr 1988;12:917-922

    PubMedWeb of Science
28. Martin E, Krassnitzer S, Kaelin P, Boesch C. MR imaging of the brainstem: normal postnatal development. Neuroradiology 1991;33:391-395

    CrossRefPubMedWeb of Science
29. Barkovich AJ. MR of the normal neonatal brain: assessment of deep structures. AJNR Am J Neuroradiol 1998;19:1397-1403

    Abstract
30. ↵
    Nomura Y, Sakuma H, Takeda K, Tagami T, Okuda Y, Nakagawa T. Diffusional anisotropy of the human brain assessed with diffusion-weighted MR: relation with normal brain development and aging. AJNR Am J Neuroradiol 1994;15:231-238

    Abstract/FREE Full Text
31. Sakuma H, Nomura Y, Takeda K, et al. Adult and neonatal human brain: diffusional anisotropy and myelination with diffusion-weighted MR imaging. Radiology 1991;180:229-233

    PubMedWeb of Science
32. ↵
    Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 1998;209:57-66

    PubMedWeb of Science
33. ↵
    Chew WM, Rowley HA, Barkovich AJ. Magnetization transfer contrast imaging in pediatric patients. Radiology 1992;185:281

    PubMed
34. ↵
    Whittall KP, MacKay AL, Graeb DA, Nugent RA, Li DK, Paty DW. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 1997;37:34-43

    CrossRefPubMedWeb of Science
35. Poduslo SE, Jang Y. Myelin development in infant brain. Biochem Res 1984;9:1615-1626
36. ↵
    Kucharczyk W, Macdonald P, Stanisz G, Henkelman RM. Relaxivity and magnetization transfer of white matter lipids at MR imaging: importance of cerebrosides and pH. Radiology 1994;192:521-529

    PubMedWeb of Science
37. ↵
    Koenig SH, Brown RD III, Spiller M, Lundbom N. Relaxometry of the brain: why white matter appears bright on MRI. Magn Reson Med 1990;14:482-495

    PubMedWeb of Science
38. ↵
    Baratti C, Barnett AS, Pierpaoli C. Comparative MR imaging study of brain maturation in kittens with T1, T2, and the trace of the diffusion tensor. Radiology 1999;210:133-142

    CrossRefPubMedWeb of Science
39. Husted C, Montez B, Le C, Moscarello MA, Oldfield E. Carbon-13 “magic-angle” sample-spinning nuclear magnetic resonance studies of human myelin, and model membrane systems. Magn Reson Med 1993;29:168-178

    PubMed
40. Husted C. Carbon-13 Magic Angle Spinning NMR Studies of Myelin Membranes. [Phd thesis]. Urbana: University of Illinois at Urbana-Champaign 1991
41. Barkovich AJ. Brain development: normal and abnormal. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. New York: Raven Press 1991 129-175
42. Wimberger D, Roberts TP, Kucharczyk J, Barkovich AJ, Kozniewska E, Prayer LM. Diffusion-weighted imaging at 4.7 T in the assessment of brain maturation in albino rats. Presented at the Society of Magnetic Resonance Imaging meeting, San Francisco, 1993
43. ↵
    Wimberger DM, Roberts TP, Barkovich AJ, Prayer LM, Moseley ME, Kucharczyk J. Identification of “premyelination” by diffusion-weighted MRI. J Comput Assist Tomogr 1995;19:28-33

    PubMedWeb of Science
44. ↵
    Dubois-Dalcq M, Feigenbaum V, Aubourg P. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 1999;22:4-12

    CrossRefPubMedWeb of Science
45. ↵
    Fouquet F, Zhou JM, Ralston E, et al. Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 1997;3:271-285

    CrossRefPubMedWeb of Science
46. ↵
    Ho JK, Moser H, Kishimoto Y, Hamilton JA. Interactions of a very long chain fatty acid with model membranes and serum albumin: implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 1995;96:1455-1463
47. ↵
    Kumar AJ, Rosenbaum AE, Naidu S, et al. Adrenoleukodystrophy: correlating MR imaging with CT. Radiology 1987;165:497-504

    PubMedWeb of Science
48. ↵
    Barkovich AJ. Toxic and metabolic brain disorders. In: Barkovich AJ, ed. Pediatric Neuroimaging. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000
49. ↵
    Gieselmann V, Polten A, Kreysing J, von Figura K. Molecular genetics of metachromatic leukodystrophy. J Inherit Metab Dis 1994;17:500-509

    CrossRefPubMedWeb of Science
50. ↵
    van der Knaap MS, Valk J. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin: Springer 1995;
51. ↵
    Woodward K, Malcolm S. Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice. Trends Genet 1999;15:125-129

    CrossRefPubMedWeb of Science
52. ↵
    Sistermans EA, de Wijs IJ, de Coo RF, Smit LM, Menko FH, van Oost BA. A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum Genet 1996;97:337-339

    PubMedWeb of Science
53. Raskind WH, Williams CA, Hudson LD, Bird TD. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Hum Genet 1991;49:1355-1360

    PubMedWeb of Science
54. ↵
    Gow A, Lazzarini RA. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet 1996;13:422-428

    CrossRefPubMedWeb of Science
55. ↵
    Gow A, Southwood CM, Lazzarini RA. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 1998;140:925-934

    Abstract/FREE Full Text
56. ↵
    Learish R, Brüstle O, Zhang S-C, Duncan I. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann Neurol 1999;46:716-722

    CrossRefPubMedWeb of Science
57. ↵
    Roth HJ, Hunkeler MJ, Campagnoni AT. Expression of myelin basic protein genes in several dysmyelinating mouse mutants during early postnatal brain development. J Neurochem 1985;45:572-580

    CrossRefPubMedWeb of Science
58. ↵
    Loevner LA, Shapiro RM, Grossman RI, Overhauser J, Kamholz J. White matter changes associated with deletions of the long arm of chromosome 18 (18q- syndrome): a dysmyelinating disorder? AJNR Am J Neuroradiol 1996;17:1843-1848

    Abstract
59. Gay CT, Hardies LJ, Rauch RA, et al. MRI demonstrates incomplete myelination in 18q- syndrome: evidence for myelin basic protein haploinsuffiency. Am J Med Genet 1997;74:422-431

    CrossRefPubMedWeb of Science
60. ↵
    Becker LE. MR findings in the central nervous system of patients with a deletion of the long arm of chromosome 18(18q-) [letter]. AJNR Am J Neuroradiol 1998;19:399

    PubMedWeb of Science
61. ↵
    Chiappa KH, Parker SW, Shahani BT. Pathoneurophysiology of multiple sclerosis. In: Koetsier JC, ed. Handbook of Clinical Neurology. Amsterdam: Elsevier 1985 131-145
62. ↵
    Kurtzke JF. Epidemiology of multiple sclerosis. In: Koetsier JC, ed. Handbook of Clinical Neurology. Amsterdam: Elsevier 1985 259-287
63. ↵
    Reindl M, Linington C, brehm U, et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999;122:2047-2056

    Abstract/FREE Full Text
64. ↵
    Raine CS, Canella B, Hauser SL, Genain CP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999;46:144-160

    CrossRefPubMedWeb of Science
65. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity of pathogenesis. Brain Pathol 1996;6:259-274

    CrossRefPubMedWeb of Science
66. Genain CP, Canella B, Hauser S, Raine C. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999;5:153-154

    CrossRefPubMedWeb of Science
67. ↵
    Grossman RI, Braffman BH, Brorson JR, Goldberg HI, Silverberg DH, Gonzalez-Scarano F. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988;169:117-122

    PubMedWeb of Science
68. ↵
    Werring DJ, Clark CA, Barker gJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626-1632

    Abstract/FREE Full Text
69. ↵
    Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619-1627

    Abstract/FREE Full Text
70. ↵
    Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491

    PubMedWeb of Science
71. Filippi M, Rocca MA, Rizzo G, et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 1998;50:1289-1293

    Abstract/FREE Full Text
72. ↵
    van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288

    Abstract/FREE Full Text
73. ↵
    van Waesberghe J, Kamphorst W, De Groot C, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754

    CrossRefPubMedWeb of Science
74. ↵
    van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617

    Abstract/FREE Full Text
75. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-67

    CrossRefPubMedWeb of Science
76. ↵
    Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-515

    PubMedWeb of Science